|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$94.3M
|
–
|
–
|
–
|
|
|
2
|
Medicxi Ventures Management
St. Helier,
Jersey
|
$27.9M
|
–
|
–
|
–
|
|
|
3
|
|
$24.8M
|
+$1.44M
|
+139,781
|
+7%
|
|
|
4
|
Avidity Partners Management
Dallas,
Texas
|
$21.3M
|
-$70.1K
|
-6,800
|
-0.4%
|
|
|
5
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$19.8M
|
–
|
–
|
–
|
|
|
6
|
|
$19M
|
+$1.56M
|
+151,281
|
+10%
|
|
|
7
|
Abingworth
London,
United Kingdom
|
$16.1M
|
–
|
–
|
–
|
|
|
8
|
683 Capital Management
New York
|
$15.1M
|
-$3.24M
|
-313,943
|
-19%
|
|
|
9
|
Vanguard Group
Malvern,
Pennsylvania
|
$12.1M
|
+$1.1M
|
+106,851
|
+11%
|
|
|
10
|
GW&K Investment Management
Boston,
Massachusetts
|
$6.67M
|
+$10.3K
|
+998
|
+0.2%
|
|
|
11
|
Gilder Gagnon Howe & Co
New York
|
$6.19M
|
-$6.34K
|
-615
|
-0.1%
|
|
|
12
|
Newtyn Management
New York
|
$5.43M
|
+$1.73M
|
+168,099
|
+53%
|
|
|
13
|
State Street
Boston,
Massachusetts
|
$5.06M
|
+$60.3K
|
+5,854
|
+1%
|
|
|
14
|
Geode Capital Management
Boston,
Massachusetts
|
$4.88M
|
+$338K
|
+32,752
|
+8%
|
|
|
15
|
StepStone Group
La Jolla,
California
|
$4.74M
|
–
|
–
|
–
|
|
|
16
|
Opaleye Management
Boston,
Massachusetts
|
$4.68M
|
+$4.3M
|
+417,500
|
New
|
|
|
17
|
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
$2.76M
|
+$394K
|
+38,230
|
+18%
|
|
|
18
|
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
$2.64M
|
–
|
–
|
–
|
|
|
19
|
Northern Trust
Chicago,
Illinois
|
$2.37M
|
+$199K
|
+19,340
|
+10%
|
|
|
20
|
MPM BioImpact
Boston,
Massachusetts
|
$2.2M
|
+$27K
|
+2,616
|
+1%
|
|
|
21
|
Charles Schwab
San Francisco,
California
|
$1.94M
|
+$171K
|
+16,574
|
+11%
|
|
|
22
|
UBS O'Connor
Chicago,
Illinois
|
$1.73M
|
–
|
–
|
–
|
|
|
23
|
|
$1.64M
|
+$1.5M
|
+145,870
|
New
|
|
|
24
|
|
$1.45M
|
-$435K
|
-42,221
|
-25%
|
|
|
25
|
Nuveen
Charlotte,
North Carolina
|
$1.21M
|
-$99.5K
|
-9,652
|
-8%
|
|
